Evidence map›Paper›PMID 27110362›Full record

ArticleBMC hematology2016

Characteristics of chronic lymphocytic leukemia in Senegal.

Abibatou Sall, Awa Oumar Touré, Fatimata Bintou Sall, Moussa Ndour, Seynabou Fall, Abdoulaye Sène, Blaise Félix Faye, Moussa Seck, Macoura Gadji, Tandakha Ndiaye Dièye and 4 more

Open access · hybridAbstract read
In one paragraph

Article in BMC hematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Response to Comment by Amato T.Haematologica · 2019
    Article
  11. Haematologica · 2019
    Article
  12. [Characteristics of chronic lymphocytic leukemia in Togo].The Pan African medical journal · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Abibatou SallHematology, Cheikh Anta Diop University, Dakar, Senegal.
Awa Oumar TouréHematology, Cheikh Anta Diop University, Dakar, Senegal.
Fatimata Bintou SallHematology, Cheikh Anta Diop University, Dakar, Senegal.
Moussa NdourHematology, Cheikh Anta Diop University, Dakar, Senegal.
Seynabou FallHematology, Aristide Le Dantec Hospital, Dakar, Senegal.
Abdoulaye SèneHematology, Cheikh Anta Diop University, Dakar, Senegal.
Blaise Félix FayeHematology, Cheikh Anta Diop University, Dakar, Senegal.
Moussa SeckHematology, Cheikh Anta Diop University, Dakar, Senegal.
Macoura GadjiHematology, Cheikh Anta Diop University, Dakar, Senegal.
Tandakha Ndiaye DièyeHematology, Cheikh Anta Diop University, Dakar, Senegal.
Claire MathiotCurie Institute, Paris, France.
Sophie ReynaudHematology, University Hospital, Nice, France.
Saliou DiopHematology, Cheikh Anta Diop University, Dakar, Senegal.
Martine RaphaëlUniversity Paris XI, Paris, France.
Cheikh Anta Diop University · SNHôpital Aristide Le Dantec · SNInstitut Curie · FRUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic lymphocytic leukemia (CLL) is a mature B-cell neoplasm characterized by the expansion of CD5-positive lymphocytes in peripheral blood. While CLL is the most common type of leukemia in Western populations, the disease is rare in Africans. Hence, clinical and laboratory data and studies of CLL in Sub Saharan populations have been limited. The aims of this study were to analyze the characteristics of senegalese patients with CLL at the time of the diagnosis and to identify the correlation between clinical characteristics (Binet stage) with age, gender, laboratory parameters and chromosomal abnormalities.

methodsIn this study, we investigated the clinical and laboratory characteristics of CLL in Senegal. A total of 40 patients who had been diagnosed with CLL during the period from July 2011 to April 2015 in Senegal were evaluated. Cytology and immunophenotype were performed in all patients to confirm the diagnosis. The prognosis factors such as Binet staging, CD38 and cytogenetic abnormalities were studied. The statistical analysis was performed using STATA version 13 (Stata college station Texas). Each patient signed a free and informed consent form before participating in the study.

resultsThe mean age was 61 years ranged from 48 to 85. There were 31 males and only 9 females (sex ratio M : F = 3,44). At diagnosic, 82.5 % of the patients were classified as having advanced Binet stages B or C. The prognosis marker CD38 was positive in 28 patients. Cytogenetic abnormalities studied by FISH were performed in 25 patients, among them, 68 % (17 cases) had at least one cytogenetic abnormality and 28 % had 2 simultaneous cytogenetic abnormalities.

conclusionAfricans may present with CLL at a younger age and our data suggest that CLL in Senegal may be more aggressive than in Western populations.

Indexed as

Chronic lymphocytic leukemiaClinicCytogenetic abnormalitiesCytologyImmunophenotype

Identifiers

PMID27110362
PMCPMC4841974
OpenAlexW2337132612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.